Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 6, 2019 - Amgen announced the FDA approval of Avsola (infliximab-axxq), a biosimilar to Janssen’s Remicade® (infliximab).
Download PDF
Return to publications
